The levels of NFL, GFAP, and ubiquitin carboxy-terminal hydrolase L1 levels L1 (UCHL1) in hospitalized COVID-19 patients without a history of dementia were as high as in non-COVID AD controls [105]. Here, GFAP is linked to COVID-19.